Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Clinical trials sponsored by Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd., explained in plain language.
-
New psoriasis pill shows promise in Mid-Stage trial
Disease control CompletedThis study tested an experimental drug called TQH3906 in 209 adults with moderate to severe plaque psoriasis. The main goal was to see how well it clears skin patches after 12 weeks of treatment. Researchers also checked for side effects and how the drug moves through the body.
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 29, 2026 01:49 UTC
-
New shot aims to quiet seasonal allergy misery
Symptom relief CompletedThis study tested an investigational injection called TQC2938 in 136 adults with seasonal allergic rhinitis (hay fever). All participants also used a standard nasal spray. The goal was to see if the injection could further reduce daily nasal symptoms like sneezing and congestion …
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Apr 29, 2026 01:49 UTC